CoChat

Activation of Nrf2 in keratinocytes causes chloracne (MADISH)-like skin disease in mice

Open access

The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.

Abstract

The transcription factor Nrf2 is a key regulator of the cellular stress response, and pharmacological Nrf2 activation is a promising strategy for skin protection and cancer prevention. We show here that prolonged Nrf2 activation in keratinocytes causes sebaceous gland enlargement and seborrhea in mice due to upregulation of the growth factor epigen, which we identified as a novel Nrf2 target. This was accompanied by thickening and hyperkeratosis of hair follicle infundibula. These abnormalities caused dilatation of infundibula, hair loss, and cyst development upon aging. Upregulation of epigen, secretory leukocyte peptidase inhibitor (Slpi), and small proline‐rich protein 2d (Sprr2d) in hair follicles was identified as the likely cause of infundibular acanthosis, hyperkeratosis, and cyst formation. These alterations were highly reminiscent to the phenotype of chloracne/“metabolizing acquired dioxin‐induced skin hamartomas” (MADISH) patients. Indeed, SLPI, SPRR2, and epigen were strongly expressed in cysts of MADISH patients and upregulated by dioxin in human keratinocytes in an NRF2‐dependent manner. These results identify novel Nrf2 activities in the pilosebaceous unit and point to a role of NRF2 in MADISH pathogenesis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/emmm.201303281

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Morphology of sebaceous glands and infundibula in K5cre-CMVcaNrf2 mice. Upper panel: H&E staining of longitudinal back skin sections. Scale bar: 100 μm. Middle and lower panel: immunofluorescence staining for Adph on longitudinal back skin (middle panel) and transverse tail skin sections (lower panel) of P32 tg/wt and tg/tg mice. Note larger SG in tg/tg back and tail. Scale bar: 50 μm.Back skin SG area in P10 (N = 7/6, **P = 0.0012) and P32 (N = 5/7, **P = 0.0025) tg/wt and tg/tg mice.Morphometrical analysis of SG area of untreated, vehicle (N = 10/6, **P = 0.0017), sulforaphane (N = 6, **P = 0.0022), and tBHQ (N = 6, **P = 0.0022) treated wt mice.Oil Red O (upper panel) and H&E staining (lower panel) of longitudinal back skin sections of P32 tg/wt and tg/tg mice. In tg/tg mice, infundibula (INF) are filled with sebum (indicated by arrow in upper panel), thickened (indicated by bar in lower panel), and hyperkeratotic (indicated by arrows in lower panel). Scale bars: 25 μm.Average thickness of infundibula (N = 5, *P = 0.0119) of tg/wt and tg/tg mice.H&E staining of longitudinal back skin sections of 8 w tg/wt and tg/tg mice. Note dilatation of infundibula in tg/tg mice. Scale bar: 50 μm. Data information: Values are shown as the mean with s.d. All P-values were calculated by Mann–Whitney U-test. AV, average; E, epidermis; D, dermis; HF, hair follicle; INF, infundibulum; SG, sebaceous gland.
Figure 1 Morphology of sebaceous glands and infundibula in K5cre-CMVcaNrf2 mice. Upper panel: H&E staining of longitudinal back skin sections. Scale bar: 100 μm. Middle and lower panel: immunofluorescence staining for Adph on longitudinal back skin (middle panel) and transverse tail skin sections (lower panel) of P32 tg/wt and tg/tg mice. Note larger SG in tg/tg back and tail. Scale bar: 50 μm.Back skin SG area in P10 (N = 7/6, **P = 0.0012) and P32 (N = 5/7, **P = 0.0025) tg/wt and tg/tg mice.Morphometrical analysis of SG area of untreated, vehicle (N = 10/6, **P = 0.0017), sulforaphane (N = 6, **P = 0.0022), and tBHQ (N = 6, **P = 0.0022) treated wt mice.Oil Red O (upper panel) and H&E staining (lower panel) of longitudinal back skin sections of P32 tg/wt and tg/tg mice. In tg/tg mice, infundibula (INF) are filled with sebum (indicated by arrow in upper panel), thickened (indicated by bar in lower panel), and hyperkeratotic (indicated by arrows in lower panel). Scale bars: 25 μm.Average thickness of infundibula (N = 5, *P = 0.0119) of tg/wt and tg/tg mice.H&E staining of longitudinal back skin sections of 8 w tg/wt and tg/tg mice. Note dilatation of infundibula in tg/tg mice. Scale bar: 50 μm. Data information: Values are shown as the mean with s.d. All P-values were calculated by Mann–Whitney U-test. AV, average; E, epidermis; D, dermis; HF, hair follicle; INF, infundibulum; SG, sebaceous gland.CC BY · PubMed Central
Figure 2 Cyclic hair loss and cutaneous cyst formation in K5cre-CMVcaNrf2 mice. Tg/tg mouse at P26, P28, P30, P32, P35, P40, and P45. Note visible hair growth at P26 to P32 (anagen) and hair loss at P35 and P40 (catagen). Arrows point to the same islet of hairs at P26 and P45.H&E staining of longitudinal back skin sections of P40 tg/wt and tg/tg mice. Note widened infundibulum (INF) and reduced anchorage of hair (indicated by dashed line in upper panel). Scale bar: 50 μm.H&E staining of longitudinal tail skin sections of 1-year (1 y)-old mice showing dilatation (indicated by arrow in left panel) and cysts (right panel) in the tail skin of tg/tg mice. Scale bar: 50 μm.Tail skin of 1-y-old tg/wt and tg/tg mice. Note large cysts in tg/tg mice.Oil red O staining of a large tail skin cyst. Note ring-shaped weak oil red O staining. Arrow points to sebum in a hair follicle. Scale bar: 100 μm.Model of the pilosebaceous phenotype in K5cre-CMVcaNrf2 mice. Left panel: scheme of the pilosebaceous unit of wild-type skin. Arrows indicate sebocyte differentiation and sebum flow (yellow) in the SG. Middle panel: scheme of the pilosebaceous unit of young K5cre-CMVcaNrf2 mice. SG hyperplasia causes seborrhea. Acanthosis and hyperkeratosis of infundibula as well as hyperkeratosis of the interfollicular epidermis impair sebum outflow. Together, this results in dilatation of infundibula. Consequently, the hair anchorage is reduced, resulting in hair loss. Right panel: In aged K5cre-CMVcaNrf2 mice, continuous keratinization leads to formation of keratinized cutaneous cysts.
Figure 2 Cyclic hair loss and cutaneous cyst formation in K5cre-CMVcaNrf2 mice. Tg/tg mouse at P26, P28, P30, P32, P35, P40, and P45. Note visible hair growth at P26 to P32 (anagen) and hair loss at P35 and P40 (catagen). Arrows point to the same islet of hairs at P26 and P45.H&E staining of longitudinal back skin sections of P40 tg/wt and tg/tg mice. Note widened infundibulum (INF) and reduced anchorage of hair (indicated by dashed line in upper panel). Scale bar: 50 μm.H&E staining of longitudinal tail skin sections of 1-year (1 y)-old mice showing dilatation (indicated by arrow in left panel) and cysts (right panel) in the tail skin of tg/tg mice. Scale bar: 50 μm.Tail skin of 1-y-old tg/wt and tg/tg mice. Note large cysts in tg/tg mice.Oil red O staining of a large tail skin cyst. Note ring-shaped weak oil red O staining. Arrow points to sebum in a hair follicle. Scale bar: 100 μm.Model of the pilosebaceous phenotype in K5cre-CMVcaNrf2 mice. Left panel: scheme of the pilosebaceous unit of wild-type skin. Arrows indicate sebocyte differentiation and sebum flow (yellow) in the SG. Middle panel: scheme of the pilosebaceous unit of young K5cre-CMVcaNrf2 mice. SG hyperplasia causes seborrhea. Acanthosis and hyperkeratosis of infundibula as well as hyperkeratosis of the interfollicular epidermis impair sebum outflow. Together, this results in dilatation of infundibula. Consequently, the hair anchorage is reduced, resulting in hair loss. Right panel: In aged K5cre-CMVcaNrf2 mice, continuous keratinization leads to formation of keratinized cutaneous cysts.CC BY · PubMed Central
Figure 3 Sebocyte proliferation, differentiation, and lipid metabolism in K5cre-CMVcaNrf2 mice. A BrdU staining on skin sections of tg/wt and tg/tg mice. Arrowheads point to BrdU-positive sebocytes. The dotted line marks the boundary of the SGs. Scale bar: 50 μm. B Quantification of BrdU-positive sebocytes per circumference of SG in P32 tg/wt and tg/tg mice (N = 4, *P = 0.0286). C, D qRT-PCR for Adph (N = 4, *P = 0.0286), Pparg (N = 4, *P = 0.0286) and Mc5r (N = 3) (C) and Scd1 (*P = 0.0286), Scd2, Scd3, and Scd4 (*P = 0.0286, N = 4) (D) relative to Gapdh using RNAs from skin of P32 control (tg/wt) and K5cre-CMVcaNrf2 (tg/tg) mice. Expression in tg/wt mice was arbitrarily set as 1 (dashed line). E qRT-PCR of Adph, Pparg and Scd1 in P2.5 control and K5cre-CMVcaNrf2 mice (N = 3). F Separation of cholesterol (Chol), free fatty acids (FA), triacylglycerides (TAG), and cholesterol-and wax esters (CE) by HPTLC in control (tg/wt) and K5cre-CMVcaNrf2 (tg/tg) mice. G Wet weight ratio of cholesterol, free fatty acids, triacylglycerides, and cholesterol-and wax esters relative to total skin protein. Note the reduction in TAG levels in tg/tg mice. H In situ hybridization on back skin sections from 8-w-old tg/wt and tg/tg mice using Epgn sense (upper panel) and antisense probes (lower panel). Note strong staining in interfollicular epidermis and pilosebaceous unit, particularly on tg/tg section hybridized with the Epgn antisense probe. Scale bar: 50 μm. I qRT-PCR of Epgn relative to Gapdh using RNAs from skin of P2.5 and P32 tg/wt and tg/tg mice (N = 3). Expression in tg/wt mice was arbitrarily set as 1 (dashed line). J qRT-PCR of epidermal growth factor (EGF) family members in P32 tg/wt and tg/tg mice (N = 3/4). Data information: Values are shown as the mean with s.d. All P-values were calculated by Mann–Whitney U-test.
Figure 3 Sebocyte proliferation, differentiation, and lipid metabolism in K5cre-CMVcaNrf2 mice. A BrdU staining on skin sections of tg/wt and tg/tg mice. Arrowheads point to BrdU-positive sebocytes. The dotted line marks the boundary of the SGs. Scale bar: 50 μm. B Quantification of BrdU-positive sebocytes per circumference of SG in P32 tg/wt and tg/tg mice (N = 4, *P = 0.0286). C, D qRT-PCR for Adph (N = 4, *P = 0.0286), Pparg (N = 4, *P = 0.0286) and Mc5r (N = 3) (C) and Scd1 (*P = 0.0286), Scd2, Scd3, and Scd4 (*P = 0.0286, N = 4) (D) relative to Gapdh using RNAs from skin of P32 control (tg/wt) and K5cre-CMVcaNrf2 (tg/tg) mice. Expression in tg/wt mice was arbitrarily set as 1 (dashed line). E qRT-PCR of Adph, Pparg and Scd1 in P2.5 control and K5cre-CMVcaNrf2 mice (N = 3). F Separation of cholesterol (Chol), free fatty acids (FA), triacylglycerides (TAG), and cholesterol-and wax esters (CE) by HPTLC in control (tg/wt) and K5cre-CMVcaNrf2 (tg/tg) mice. G Wet weight ratio of cholesterol, free fatty acids, triacylglycerides, and cholesterol-and wax esters relative to total skin protein. Note the reduction in TAG levels in tg/tg mice. H In situ hybridization on back skin sections from 8-w-old tg/wt and tg/tg mice using Epgn sense (upper panel) and antisense probes (lower panel). Note strong staining in interfollicular epidermis and pilosebaceous unit, particularly on tg/tg section hybridized with the Epgn antisense probe. Scale bar: 50 μm. I qRT-PCR of Epgn relative to Gapdh using RNAs from skin of P2.5 and P32 tg/wt and tg/tg mice (N = 3). Expression in tg/wt mice was arbitrarily set as 1 (dashed line). J qRT-PCR of epidermal growth factor (EGF) family members in P32 tg/wt and tg/tg mice (N = 3/4). Data information: Values are shown as the mean with s.d. All P-values were calculated by Mann–Whitney U-test.CC BY · PubMed Central
Figure 4 Regulation of Epgn by Nrf2. A Average SG area of P32 tg/wt and tg/tg mice injected with vehicle or Gefitinib. Note reduction in SG area upon Gefitinib treatment of tg/wt mice (N = 6/5, **P = 0.0025) and tg/tg mice (N = 4, *P = 0.0286). B, C qRT-PCR of Adph, Pparg Mc5r (B), and Scd1, 2, 3, 4 (C) relative to Gapdh using RNA of back skin from wt and EPGN-tg mice (N = 3). D, E qRT-PCR of Epgn using RNAs of murine primary keratinocytes of tg/wt and tg/tg mice (N = 3) (D), or immortalized keratinocytes of wt and Nrf2ko mice treated with vehicle or sulforaphane (E) (N = 4, *P = 0.0286). F Localization of PCR-amplified non-specific region (ns), promoter region (prom), and antioxidant response elements (AREs) in the murine Nqo1 and Epgn genes. G Chromatin immunoprecipitation (ChIP) using lysates from back and tail skin of control mice. Note the enhanced binding of Nrf2 to the Epgn ARE compared with the ns region (Nqo1 ns, N = 6, Nqo1 ARE, N = 6, **P = 0.0045; Epgn ARE, N = 4, *P = 0.012). H, I ChIP using back and tail skin lysates of tg/wt (H) and tg/tg mice (I) with an H3K4me2 antibody. Regions void of annotated ORFs (non-coding, nc DNA), Epgn prom, and Epgn ARE were amplified by qRT-PCR. Note the increase in histone H3 dimethylation at the Epgn ARE compared with ncDNA in tg/tg mice (N = 2/3). J Working model: Nrf2 activation leads to increased Epgn expression, which activates EGFR signaling. This enhances proliferation of sebocyte progenitors, leading to sebaceous gland hyperplasia. Data information: Values are shown as the mean with s.d. All P-values were calculated by Mann–Whitney U-test.
Figure 4 Regulation of Epgn by Nrf2. A Average SG area of P32 tg/wt and tg/tg mice injected with vehicle or Gefitinib. Note reduction in SG area upon Gefitinib treatment of tg/wt mice (N = 6/5, **P = 0.0025) and tg/tg mice (N = 4, *P = 0.0286). B, C qRT-PCR of Adph, Pparg Mc5r (B), and Scd1, 2, 3, 4 (C) relative to Gapdh using RNA of back skin from wt and EPGN-tg mice (N = 3). D, E qRT-PCR of Epgn using RNAs of murine primary keratinocytes of tg/wt and tg/tg mice (N = 3) (D), or immortalized keratinocytes of wt and Nrf2ko mice treated with vehicle or sulforaphane (E) (N = 4, *P = 0.0286). F Localization of PCR-amplified non-specific region (ns), promoter region (prom), and antioxidant response elements (AREs) in the murine Nqo1 and Epgn genes. G Chromatin immunoprecipitation (ChIP) using lysates from back and tail skin of control mice. Note the enhanced binding of Nrf2 to the Epgn ARE compared with the ns region (Nqo1 ns, N = 6, Nqo1 ARE, N = 6, **P = 0.0045; Epgn ARE, N = 4, *P = 0.012). H, I ChIP using back and tail skin lysates of tg/wt (H) and tg/tg mice (I) with an H3K4me2 antibody. Regions void of annotated ORFs (non-coding, nc DNA), Epgn prom, and Epgn ARE were amplified by qRT-PCR. Note the increase in histone H3 dimethylation at the Epgn ARE compared with ncDNA in tg/tg mice (N = 2/3). J Working model: Nrf2 activation leads to increased Epgn expression, which activates EGFR signaling. This enhances proliferation of sebocyte progenitors, leading to sebaceous gland hyperplasia. Data information: Values are shown as the mean with s.d. All P-values were calculated by Mann–Whitney U-test.CC BY · PubMed Central
Figure 5 Sprr2d and Slpi expression in infundibula of K5cre-CMVcaNrf2 mice. A Average number of BrdU-positive cells in infundibula (INF) of tg/wt and tg/tg mice (N = 4). B,C Average thickness of infundibula and number of PCNA-positive cells in infundibula of P32 tg/wt and tg/tg mice injected with vehicle or Gefitinib (N = 4/5). D Upper panel: immunohistochemistry of Sprr2 on longitudinal P10 tg/wt and tg/tg back skin sections. Note staining of Sprr2 in differentiated infundibular keratinocytes in tg/tg mice. Scale bar: 25 μm. Middle panel: toluidine blue staining for detection of mast cells on longitudinal back skin sections of P32 tg/wt and tg/tg mice. Note increase in number of mast cells in tg/tg mice and assembly of mast cells along the interfollicular epidermis and upper part of the hair follicles. Scale bar: 100 μm. Lower panel: immunohistochemistry of Slpi on longitudinal P10 tg/wt and tg/tg back skin sections. Inset in lower panel shows immunohistochemistry without primary antibody. The dashed line marks the basement membrane of the interfollicular epidermis. Note staining of Slpi (indicated by arrow) in differentiated infundibular keratinocytes and stratum corneum in tg/tg mice. Scale bar: 25 μm. E Electron microscopy of infundibular stratum corneum of P32 tg/wt and tg/tg mice. Corneocyte layers in lower panel were numbered from basal to distal (C1–C3). Arrows point to corneodesmosomes. Note delayed corneodesmosome degradation in tg/tg mice. C, corneocyte. F Working model: Nrf2 activation leads to upregulation of Slpi, Sprr2d, and Epgn in hair follicle infundibula. Slpi upregulation promotes inhibition of CE protease activity. Consequently, corneodesmosome cleavage is reduced, leading to decreased desquamation and thereby to hyperkeratosis of infundibula. Sprr2d upregulation reduces epidermal barrier functionality, resulting in increased inflammation and consequently stimulation of proliferation. Epgn and other epidermal growth factor (EGF) family members stimulate proliferation of infundibular keratinocytes via EGFR signaling. Together, this results in acanthosis of hair follicle infundibula. Data information: Values are shown as the mean with s.d.
Figure 5 Sprr2d and Slpi expression in infundibula of K5cre-CMVcaNrf2 mice. A Average number of BrdU-positive cells in infundibula (INF) of tg/wt and tg/tg mice (N = 4). B,C Average thickness of infundibula and number of PCNA-positive cells in infundibula of P32 tg/wt and tg/tg mice injected with vehicle or Gefitinib (N = 4/5). D Upper panel: immunohistochemistry of Sprr2 on longitudinal P10 tg/wt and tg/tg back skin sections. Note staining of Sprr2 in differentiated infundibular keratinocytes in tg/tg mice. Scale bar: 25 μm. Middle panel: toluidine blue staining for detection of mast cells on longitudinal back skin sections of P32 tg/wt and tg/tg mice. Note increase in number of mast cells in tg/tg mice and assembly of mast cells along the interfollicular epidermis and upper part of the hair follicles. Scale bar: 100 μm. Lower panel: immunohistochemistry of Slpi on longitudinal P10 tg/wt and tg/tg back skin sections. Inset in lower panel shows immunohistochemistry without primary antibody. The dashed line marks the basement membrane of the interfollicular epidermis. Note staining of Slpi (indicated by arrow) in differentiated infundibular keratinocytes and stratum corneum in tg/tg mice. Scale bar: 25 μm. E Electron microscopy of infundibular stratum corneum of P32 tg/wt and tg/tg mice. Corneocyte layers in lower panel were numbered from basal to distal (C1–C3). Arrows point to corneodesmosomes. Note delayed corneodesmosome degradation in tg/tg mice. C, corneocyte. F Working model: Nrf2 activation leads to upregulation of Slpi, Sprr2d, and Epgn in hair follicle infundibula. Slpi upregulation promotes inhibition of CE protease activity. Consequently, corneodesmosome cleavage is reduced, leading to decreased desquamation and thereby to hyperkeratosis of infundibula. Sprr2d upregulation reduces epidermal barrier functionality, resulting in increased inflammation and consequently stimulation of proliferation. Epgn and other epidermal growth factor (EGF) family members stimulate proliferation of infundibular keratinocytes via EGFR signaling. Together, this results in acanthosis of hair follicle infundibula. Data information: Values are shown as the mean with s.d.CC BY · PubMed Central
Figure 6 Differential regulation of Nrf2 target genes in K5cre-CMVcaNrf2 mice. A–E qRT-PCR for Nqo1, Srxn1, Epgn, Sprr2d, and Slpi relative to Gapdh using RNAs from skin of P2.5, P32, 6-m-and 1-y-old tg/wt and tg/tg mice (N = 3/4). Expression in tg/wt mice was arbitrarily set as 1. F Immunohistochemistry of Slpi on 1 y tg/wt and tg/tg back skin sections. Note strong staining of Slpi in cyst epithelium and keratinized lumen compared with differentiated keratinocytes of the epidermis (indicated by arrow). Scale bar: 100 μm. Data information: Values are shown as the mean with s.d.
Figure 6 Differential regulation of Nrf2 target genes in K5cre-CMVcaNrf2 mice. A–E qRT-PCR for Nqo1, Srxn1, Epgn, Sprr2d, and Slpi relative to Gapdh using RNAs from skin of P2.5, P32, 6-m-and 1-y-old tg/wt and tg/tg mice (N = 3/4). Expression in tg/wt mice was arbitrarily set as 1. F Immunohistochemistry of Slpi on 1 y tg/wt and tg/tg back skin sections. Note strong staining of Slpi in cyst epithelium and keratinized lumen compared with differentiated keratinocytes of the epidermis (indicated by arrow). Scale bar: 100 μm. Data information: Values are shown as the mean with s.d.CC BY · PubMed Central
Figure 7 Histopathological features and expression of SPRR2D and SLPI in MADISH patients. A Left: transverse section of tail skin from 1-y-old K5cre-CMVcaNrf2 mouse with large cyst. Middle: section of pre-auricular skin biopsy of a MADISH patient. Right: close-up as indicated by rectangle in middle picture. Note lack of SGs and large cutaneous keratinized cysts in skin section of K5cre-CMVcaNrf2 mouse and MADISH patient. B, C Immunohistochemistry staining of SPRR2 (B) and SLPI (C) on skin section of MADISH patients. Left upper picture in (B): negative control lacking primary antibody and with secondary antibody used for SPRR2 and SLPI staining. Left upper picture in (C): SLPI staining in cyst epithelium. Right upper picture: SPRR2 (B) and SLPI staining (C) in epidermis (arrow). Lower panel: cyst in overview (left) and close-up as indicated by rectangle. Note strong SPRR2 and SLPI staining in differentiated cyst keratinocytes and epidermis (arrow). Scale bars: 100 μm (left), 50 μm (right). D, E Immunohistochemistry of NQO1 and EPGN on skin section of MADISH patient. Upper left picture: negative control secondary antibody only. Upper right picture: NQO1 (D) and EPGN staining (E) in epidermis. Lower panel: cyst in overview (left) and close-up as indicated by rectangle. Note strong NQO1 staining in differentiated keratinocytes and strong EPGN staining in all keratinocytes of cysts and epidermis (arrow). Inset in lower left panel in (E) shows EPGN staining in endothelial cells (positive control). Scale bars: 100 μm (left) and 50 μm (right).
Figure 7 Histopathological features and expression of SPRR2D and SLPI in MADISH patients. A Left: transverse section of tail skin from 1-y-old K5cre-CMVcaNrf2 mouse with large cyst. Middle: section of pre-auricular skin biopsy of a MADISH patient. Right: close-up as indicated by rectangle in middle picture. Note lack of SGs and large cutaneous keratinized cysts in skin section of K5cre-CMVcaNrf2 mouse and MADISH patient. B, C Immunohistochemistry staining of SPRR2 (B) and SLPI (C) on skin section of MADISH patients. Left upper picture in (B): negative control lacking primary antibody and with secondary antibody used for SPRR2 and SLPI staining. Left upper picture in (C): SLPI staining in cyst epithelium. Right upper picture: SPRR2 (B) and SLPI staining (C) in epidermis (arrow). Lower panel: cyst in overview (left) and close-up as indicated by rectangle. Note strong SPRR2 and SLPI staining in differentiated cyst keratinocytes and epidermis (arrow). Scale bars: 100 μm (left), 50 μm (right). D, E Immunohistochemistry of NQO1 and EPGN on skin section of MADISH patient. Upper left picture: negative control secondary antibody only. Upper right picture: NQO1 (D) and EPGN staining (E) in epidermis. Lower panel: cyst in overview (left) and close-up as indicated by rectangle. Note strong NQO1 staining in differentiated keratinocytes and strong EPGN staining in all keratinocytes of cysts and epidermis (arrow). Inset in lower left panel in (E) shows EPGN staining in endothelial cells (positive control). Scale bars: 100 μm (left) and 50 μm (right).CC BY · PubMed Central
Figure 8 TCDD upregulates SLPI, SPRR2D, and EPGN in an AHR-and NRF2-dependent manner in human foreskin keratinocytes. A–C qRT-PCR for SLPI, SPRR2D, and EPGN (A), CYP1A1 and CYP1B1 (B), NRF2, NQO1, SRXN1, and GCLC (C), relative to GAPDH using RNAs from 10−8 M TCDD and vehicle-treated human foreskin keratinocytes (HFKs) (N = 3). Expression in vehicle-treated HFKs was arbitrarily set as 1. D, E qRT-PCR of NQO1, SLPI, SPRR2D, and EPGN relative to GAPDH using RNA from HFKs transfected with siRNA targeting NRF2 (Nrf2-2 or Nrf2-7) (D) or AHR (AHR1 or AHR2) (E) or scrambled (scr) siRNA (D,E) (N = 3/4). Cells were treated with 10−8 M TCDD or vehicle. Note downregulation of NQO1, SLPI, SPRR2D, and EPGN in cells transfected with siRNAs targeting NRF2 or AHR. Data information: Values are shown as the mean with s.d.
Figure 8 TCDD upregulates SLPI, SPRR2D, and EPGN in an AHR-and NRF2-dependent manner in human foreskin keratinocytes. A–C qRT-PCR for SLPI, SPRR2D, and EPGN (A), CYP1A1 and CYP1B1 (B), NRF2, NQO1, SRXN1, and GCLC (C), relative to GAPDH using RNAs from 10−8 M TCDD and vehicle-treated human foreskin keratinocytes (HFKs) (N = 3). Expression in vehicle-treated HFKs was arbitrarily set as 1. D, E qRT-PCR of NQO1, SLPI, SPRR2D, and EPGN relative to GAPDH using RNA from HFKs transfected with siRNA targeting NRF2 (Nrf2-2 or Nrf2-7) (D) or AHR (AHR1 or AHR2) (E) or scrambled (scr) siRNA (D,E) (N = 3/4). Cells were treated with 10−8 M TCDD or vehicle. Note downregulation of NQO1, SLPI, SPRR2D, and EPGN in cells transfected with siRNAs targeting NRF2 or AHR. Data information: Values are shown as the mean with s.d.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 42 references

Cited by

Items 101–102 of 102

Metadata

Authors
Schäfer, M., Willrodt, A., Kurinna, S., Link, A. S., Farwanah, H., Geusau, A., Gruber, F., Sorg, O., Huebner, A. J., Roop, D. R., Sandhoff, K., Saurat, J., Tschachler, E., Schneider, M. R., Langbein, L., Bloch, W., Beer, H., & Werner, S.
Affiliations
  • ETH Zurich (CH)
  • Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
  • University of Bonn (DE)
  • Medical University of Vienna (AT)
  • University of Geneva (CH)
  • University of Colorado Denver (US)
  • Ludwig-Maximilians-Universität München (DE)
  • German Cancer Research Center (DE)
  • German Sport University Cologne (DE)
  • University Hospital Zurich (CH)
Corresponding author
Schäfer, Matthias
Venue
EMBO Molecular Medicine
Published
2014-02-06
Volume
6
Issue
4
Pages
442-457
ISSN
  • 1757-4676 (ISSN-L)
  • 1757-4684
OpenAlex
W2130008458
Cited by
98
References
43
Citations by year
2026: 5 · 2025: 7 · 2024: 2 · 2023: 4 · 2022: 7 · 2021: 11 · 2020: 8 · 2019: 5 · 2018: 10 · 2017: 9 · 2016: 10 · 2015: 15 · 2014: 4
FWCI
5.19
Type
journal article
Language
en
Open access
Licence
Locations
  • EMBO Molecular Medicine (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Open access LMU (Ludwid Maxmilian's Universitat Munchen) (submittedVersion)
  • Research Explorer (The University of Manchester) (submittedVersion)
  • Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
  • Repository for Publications and Research Data (ETH Zurich) (submittedVersion, cc-by)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by)
  • ETH Zürich Research Collection (cc-by)
  • Zurich Open Repository and Archive (University of Zurich)
Funders
  • Swiss National Science Foundation (CRSI33_130576/1, 310030_132884/1)
  • Promedica Foundation
  • CE.R.I.E.S.
  • EMBO postdoctoral fellowship
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
  • Health Sciences › Medicine › Dermatology › Hair Growth and Disorders
  • Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
Keywords
Nrf2, keratinocytes, chloracne, seborrhea, hair follicle infundibulum, hyperkeratosis, pilosebaceous unit, secretory leukocyte protease inhibitor, dioxins, hair cysts, hair loss, epigenetic regulation
MeSH terms
Animals, Cells, Cultured, Disease Models, Animal, Humans, Mice, Transgenic, Keratinocytes, Hair Follicle, NF-E2-Related Factor 2, Mice, Secretory Leukocyte Peptidase Inhibitor, Chloracne, Epigen

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.